Skip to main content
OpenTrials
Completed

NCT Number: NCT07447518

Double j Stent Related Symptoms

In urology, ureteral stents are used to treat obstructive diseases. Hematuria (54%), fever, discomfort, and lower urinary system symptoms are the predominant symptoms related to ureteral stent.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lower Urinary Tract Symptoms Pathological Conditions, Signs and Symptoms Signs and Symptoms Urological Manifestations

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Elsayed Abdelhalim

Zagazig, 44749, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age above 18 years
  • any patient need post urs or pcnl double stent

Exclusion criteria

  • age less than 18 years
  • known over active bladder patient

Treatment and study plan

Tadalafil 5mg

Drug

once daily 5mg

solidosin

Drug

once daily

Solfenacin

Drug

once dialy

Mirabegron

Drug

once daily

Placebo

Drug

once daily

Primary outcomes

  1. Double j related symptoms

    Time frame: Six weeks

    Double j related symptoms questionnaire score

Secondary outcomes

  1. Sex matters related double j stent

    Time frame: Six weeks

    Sex matters related stent

Sponsors and collaborators

Lead sponsor

Kafrelsheikh University

Other

Registry information

Official study title

Comparison of Mirabegron ,Tamsulosin and Solifenacinin Relieving Double -J Stent Related Symptoms : Approspective Randmized Placebo Controlledtrial

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 3, 2026
Registry last updated
Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.